Long-term outcome after the Ross procedure in 173 adults with up to 25 years of follow-up (2024)

FAQs

What are the long term results of the Ross procedure? ›

The 30-day mortality after the first Ross-related reintervention was 0%, and after all Ross-related reinterventions was 3.8% (n = 1). The 10-year survival rate after reoperation was 96.2% (95% CI, 89.0-100%). The probability of developing higher grades of AR increased over time.

One perioperative death occurred. By 25 years, the survival rate for patients who underwent the Ross procedure was 83.0%, nearly matching the 83.7% survival rate seen in the general population (matched for age, country of origin, and sex).

Survival at 20 years was 93.6% and similar to the general population matched for age and sex.

While the Ross procedure is less invasive than other open-heart surgeries, you will still have a hospital stay of approximately four days and restricted activity for up to eight weeks after the operation.

Immediately after the operation, you will stay in the intensive care unit (ICU) for one to two days. Then you will move to a recovery room for another three to four days. It takes up to three to four weeks to recover from a Ross procedure. You'll avoid heavy lifting during this period.

Potential complications with the Ross procedure include[5]: Aortic insufficiency. Right ventricular outlet obstruction. Aortic autograft dilatation.

In the NIHR study, bioprosthetic valves appeared safe, and they were linked to average lifespans when matched to the population having surgery. Ten years after replacement, the great majority of people (94%) had a functioning valve. After 20 years, more valves had failed, with 48% of valves deteriorating.

As with any surgery, the Ross procedure may involve certain risks and complications. They include: Bleeding and infection. Stroke, heart attack.

Seventy-seven-year-old Anne Bell, from Banknock in Falkirk, is the longest surviving recipient of a single artificial heart valve replacement.

However, the Ross procedure accounts for less than 0.1% of all aortic valve replacements performed in the United States (15).

What medications are given after the Ross procedure? ›

Following the Ross procedure, patients may be prescribed medications such as beta blockers to control blood pressure as the pulmonary valve begins its new function as an aortic valve.

“We're able to show that even with the added complexity of surgery that has additional procedures or is a re-operative surgery, outcomes for our Ross patients can still be excellent. Our survival rate is 100 percent, and the risk of reoperation for either the aortic or the conduit pulmonary valve is very low.”

Almost as many (90%) can go 20 years. Most people don't need another mitral valve surgery after a successful repair. You'll need an echocardiogram each year so your provider can check on your valve function. You may also need antibiotics before certain procedures to prevent endocarditis (an infection of your valve).

Many heart-healthy lifestyle changes can help reduce the symptoms of heart valve disease, and in some cases, may even prevent the progression of certain symptoms. Eating a heart- healthy diet, aiming for a healthy weight, engaging in regular physical exercise, and managing your stress can help.

There were 8 (5%) early deaths, 6 of whom underwent the Ross-Konno procedure, and 10 (7%) late deaths. Survival rates at 15 and 20 years were 86% in the total cohort and 91% in the isolated Ross subgroup.

The estimated freedom from reoperation was 88% at 10 years, 83% at 20 years, and 78% at 30 years after initial CAVSD repair. Indications for reoperation included left atrioventricular valve regurgitation in 14 patients (7.1%) and left ventricular outflow obstruction in 7 patients (3.5%).

There were 8 (5%) early deaths, 6 of whom underwent the Ross-Konno procedure, and 10 (7%) late deaths. Survival rates at 15 and 20 years were 86% in the total cohort and 91% in the isolated Ross subgroup.

Successful cyclodialysis cleft repair can lead to a good long-term visual prognosis and stable IOP control, even in cases with a protracted history of ocular hypotony.